KWILP
RARE icon

Kiwi Wealth Investments Limited Partnership’s Ultragenyx Pharmaceutical RARE Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,552
Closed -$958K – 192
2018
Q3 		$958K Buy
+12,552
New +$1.02M 0.09% 165

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's RARE Position: Q4 2018 in Review

Kiwi Wealth Investments Limited Partnership sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2018, closing a stake of 12,552 shares — an estimated $958K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in RARE in Q3 2018 and held it in 1 quarter. The position peaked at $958K in Q3 2018. 165 funds tracked by Wall St. Rank hold RARE as of Q4 2018.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Ultragenyx Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 12,552 Ultragenyx Pharmaceutical shares in Q4 2018, an estimated $958K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Ultragenyx Pharmaceutical in Q3 2018 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Ultragenyx Pharmaceutical position peaked at $958K in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2018.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q4 2018, filed 14 Feb 2019.